ribosome

  • All (22)
  • ribosome Inhibitors (17)
  • New ribosome Products
Cat.No. Product Name Information Product Use Citations Product Validations
S1773 Oxytetracycline (Terramycin) Oxytetracycline (Terramycin) is a broad-spectrum tetracycline antibiotic used to treat infections with bacteria.
Sci Rep, 2018, 8(1):7653
Front Microbiol, 2016, 7: 1765
Verified customer review of Oxytetracycline (Terramycin)
E4932 Amikacin Amikacin(BAY 41-6551, Lukadin) is a semisynthetic aminoglycoside, derived from kanamycin-A, that acts as an inhibitor of the Z ring formation, leading to the inhibition of cell division. It is used to treat serious infections caused by aerobic Gram-negative bacteria, mycobacteria, Nocardia, and life-threatening infections in neonates.
S7417 Puromycin Dihydrochloride Puromycin 2HCl is an aminonucleoside antibiotic derived from Streptomyces alboniger. It is an inhibitor of protein synthesis and has been used to study transcription regulatory mechanisms that control the sequential and coordinated expression of genes during cell differentiation.
Signal Transduct Target Ther, 2025, 10(1):182
Cell Stem Cell, 2025, S1934-5909(25)00181-X
Nat Commun, 2025, 16(1):4792
S4163 Doxycycline Hyclate Doxycycline Hyclate is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. It is also an inhibitor of matrix metallo-proteinases (MMP).
Cell Discov, 2025, 11(1):41
Adv Sci (Weinh), 2025, 12(41):e03977
Dev Cell, 2025, S1534-5807(25)00405-8
S5159 Doxycycline Doxycycline (Vibramycin, Doxytetracycline, Doxiciclina, Doxycyclinum) is an antibiotic that is used in the treatment of a number of types of infections caused by bacteria and protozoa. Doxycycline is also a nonspecific matrix metalloproteinase (MMP) inhibitor.
Nature, 2025, 10.1038/s41586-025-09222-5
Cell Stem Cell, 2025, S1934-5909(25)00181-X
Nat Commun, 2025, 16(1):7898
S1403 Tigecycline Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. This compound induces autophagy by downregulating the PI3K-AKT-mTOR pathway.
J Infect Dis, 2025, 232(3):e416-e420
NPJ Antimicrob Resist, 2025, 3(1):12
Int J Mol Sci, 2024, 25(9)4887
Verified customer review of Tigecycline
S2572 Streptomycin sulfate Streptomycin sulfate(Phytomycin) is a sulfate salt of streptomycin that is a protein synthesis inhibitor.
Front. Oncol, 2023-, Volume 13
Front Oncol, 2023, 13:1118268
Transl Oncol, 2022, 26:101502
S2908 Hygromycin B Hygromycin B (Hygrovetine), a selective antibiotic that is effective on most bacteria, fungi and higher eukaryotes, inhibits protein synthesis by interfering with translocation and causing mistranslation at the 70S ribosome.
Nat Commun, 2024, 15(1):10594
Redox Biol, 2024, 76:103349
Front Pharmacol, 2024, 15:1432851
S4147 Azithromycin Dihydrate Azithromycin Dihydrate(CP-62993 dihydrate) is an acid stable orally administered macrolide antimicrobial drug, structurally related to erythromycin.
J Cell Biochem, 2022, 10.1002/jcb.30213
Adv Ther (Weinh), 2020, 2000034
PLoS Comput Biol, 2020, 16(12):e1008489
S2555 Clarithromycin Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections.
Circulation, 2024, 150(7):563-576
Microorganisms, 2022, 10(7)1421
Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5
S1635 Erythromycin Erythromycin (E-Mycin) is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin (IC50=1.5 μg/ml).
Autophagy, 2025, 1-17.
Infect Drug Resist, 2023, 16:4867-4879
Infect Drug Resist, 2023, 16:4867-4879
S2574 Tetracycline HCl Tetracycline HCl (NCI-c55561) is a hydrochloride salt of tetracycline that is a broad-spectrum polyketide antibiotic.
Nat Commun, 2024, 15(1):2377
Antiviral Res, 2020, 185:104993
PLoS Pathog, 2020, 16;16(3):e1008341
S4056 Retapamulin Retapamulin (SB-275833) is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
Infect Drug Resist, 2023, 16:4867-4879
Infect Drug Resist, 2023, 16:4867-4879
Pediatr Infect Dis J, 2021, 40(7):637-638
S1677 Chloramphenicol Chloramphenicol (Chloromycetin) is a bacteriostatic by inhibiting protein synthesis.
Cell Rep, 2021, 34(3):108631
EMBO Rep, 2021, e53081
Oncotarget, 2018, 9(40):26086-26095
S4279 Demeclocycline HCl Demeclocycline HCl(Demeclocycline hydrochloride) is a tetracycline antibiotic via inhibition of protein synthesis by bacteria, used for the treatment of bacterial infections.
Cancer Res Commun, 2025, 10.1158/2767-9764.CRC-24-0433
J Biol Chem, 2020, 10.1074/jbc.RA119.011633.
Sci Rep, 2018, 8(1):7653
S2510 Spectinomycin 2HCl Spectinomycin 2HCl (Actinospectacin) is a new parenteral antibiotic prepared from Streptomyces spectabilis.
Cell Rep, 2020, 32(2):107897
S2514 Tobramycin Tobramycin (NSC 180514,Deoxykanamycin B, Nebramycin Factor 6) is an aminoglycoside antibiotic with an IC50 of 9.7 μM.
Oncotarget, 2018, 9(40):26086-26095
S4490 Tetracycline Tetracycline (TC) is a broad-spectrum antibiotic that exhibits activity against a wide range of microorganisms including gram-positive and gram-negative bacteria, chlamydiae, mycoplasmas, rickettsiae, and protozoan parasites.
Redox Biol, 2025, 84:103649
bioRxiv, 2025, 2025.01.08.632009
PeerJ, 2022, 10:e13719
S3496 Lefamulin acetate (Xenleta) Lefamulin acetate (Xenleta, BC-3781 acetate) is a pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP) treatment. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of transfer RNA for peptide transfer.
J Biol Chem, 2022, 298(5):101909
S2315 Kanamycin sulfate Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan) is an aminoglycoside antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections.
Heliyon, 2024, 10(11):e32571
Oncotarget, 2018, 9(40):26086-26095
S5417 Spectinomycin dihydrochloride pentahydrate Spectinomycin dihydrochloride pentahydrate (Trobicin) is a widely used antibiotic that inhibits bacterial protein synthesis by blocking translocation of messenger RNA and transfer RNAs on the ribosome.
E4867 Omadacycline Omadacycline(Amadacycline) is an oral aminomethylcycline antibacterial antibiotic used to treat moderate-to-severe infections, such as community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This compound has broad-spectrum antibacterial activity and is effective against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria.
S1773 Oxytetracycline (Terramycin) Oxytetracycline (Terramycin) is a broad-spectrum tetracycline antibiotic used to treat infections with bacteria.
Sci Rep, 2018, 8(1):7653
Front Microbiol, 2016, 7: 1765
Verified customer review of Oxytetracycline (Terramycin)
S7417 Puromycin Dihydrochloride Puromycin 2HCl is an aminonucleoside antibiotic derived from Streptomyces alboniger. It is an inhibitor of protein synthesis and has been used to study transcription regulatory mechanisms that control the sequential and coordinated expression of genes during cell differentiation.
Signal Transduct Target Ther, 2025, 10(1):182
Cell Stem Cell, 2025, S1934-5909(25)00181-X
Nat Commun, 2025, 16(1):4792
S4163 Doxycycline Hyclate Doxycycline Hyclate is a member of the tetracycline antibiotics group, and is commonly used to treat a variety of infections. It is also an inhibitor of matrix metallo-proteinases (MMP).
Cell Discov, 2025, 11(1):41
Adv Sci (Weinh), 2025, 12(41):e03977
Dev Cell, 2025, S1534-5807(25)00405-8
S5159 Doxycycline Doxycycline (Vibramycin, Doxytetracycline, Doxiciclina, Doxycyclinum) is an antibiotic that is used in the treatment of a number of types of infections caused by bacteria and protozoa. Doxycycline is also a nonspecific matrix metalloproteinase (MMP) inhibitor.
Nature, 2025, 10.1038/s41586-025-09222-5
Cell Stem Cell, 2025, S1934-5909(25)00181-X
Nat Commun, 2025, 16(1):7898
S1403 Tigecycline Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation. This compound induces autophagy by downregulating the PI3K-AKT-mTOR pathway.
J Infect Dis, 2025, 232(3):e416-e420
NPJ Antimicrob Resist, 2025, 3(1):12
Int J Mol Sci, 2024, 25(9)4887
Verified customer review of Tigecycline
S2572 Streptomycin sulfate Streptomycin sulfate(Phytomycin) is a sulfate salt of streptomycin that is a protein synthesis inhibitor.
Front. Oncol, 2023-, Volume 13
Front Oncol, 2023, 13:1118268
Transl Oncol, 2022, 26:101502
S2908 Hygromycin B Hygromycin B (Hygrovetine), a selective antibiotic that is effective on most bacteria, fungi and higher eukaryotes, inhibits protein synthesis by interfering with translocation and causing mistranslation at the 70S ribosome.
Nat Commun, 2024, 15(1):10594
Redox Biol, 2024, 76:103349
Front Pharmacol, 2024, 15:1432851
S2555 Clarithromycin Clarithromycin (A-56268) is a macrolide antibiotic and a CYP3A4 inhibitor, used to treat a number of bacterial infections.
Circulation, 2024, 150(7):563-576
Microorganisms, 2022, 10(7)1421
Cell Biol Toxicol, 2021, 10.1007/s10565-021-09646-5
S1635 Erythromycin Erythromycin (E-Mycin) is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin (IC50=1.5 μg/ml).
Autophagy, 2025, 1-17.
Infect Drug Resist, 2023, 16:4867-4879
Infect Drug Resist, 2023, 16:4867-4879
S2574 Tetracycline HCl Tetracycline HCl (NCI-c55561) is a hydrochloride salt of tetracycline that is a broad-spectrum polyketide antibiotic.
Nat Commun, 2024, 15(1):2377
Antiviral Res, 2020, 185:104993
PLoS Pathog, 2020, 16;16(3):e1008341
S1677 Chloramphenicol Chloramphenicol (Chloromycetin) is a bacteriostatic by inhibiting protein synthesis.
Cell Rep, 2021, 34(3):108631
EMBO Rep, 2021, e53081
Oncotarget, 2018, 9(40):26086-26095
S2510 Spectinomycin 2HCl Spectinomycin 2HCl (Actinospectacin) is a new parenteral antibiotic prepared from Streptomyces spectabilis.
Cell Rep, 2020, 32(2):107897
S2514 Tobramycin Tobramycin (NSC 180514,Deoxykanamycin B, Nebramycin Factor 6) is an aminoglycoside antibiotic with an IC50 of 9.7 μM.
Oncotarget, 2018, 9(40):26086-26095
S4490 Tetracycline Tetracycline (TC) is a broad-spectrum antibiotic that exhibits activity against a wide range of microorganisms including gram-positive and gram-negative bacteria, chlamydiae, mycoplasmas, rickettsiae, and protozoan parasites.
Redox Biol, 2025, 84:103649
bioRxiv, 2025, 2025.01.08.632009
PeerJ, 2022, 10:e13719
S3496 Lefamulin acetate (Xenleta) Lefamulin acetate (Xenleta, BC-3781 acetate) is a pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP) treatment. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of transfer RNA for peptide transfer.
J Biol Chem, 2022, 298(5):101909
S2315 Kanamycin sulfate Kanamycin sulfate (Kanamycin monosulfate, Ophtalmokalixan) is an aminoglycoside antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections.
Heliyon, 2024, 10(11):e32571
Oncotarget, 2018, 9(40):26086-26095
E4867 Omadacycline Omadacycline(Amadacycline) is an oral aminomethylcycline antibacterial antibiotic used to treat moderate-to-severe infections, such as community-acquired pneumonia and acute bacterial skin and skin structure infections caused by susceptible organisms. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. This compound has broad-spectrum antibacterial activity and is effective against Gram-positive and Gram-negative aerobic, anaerobic, and atypical bacteria.